The two lawsuits against Moderna, Pfizer and its partner BioNTech alleges patent infringement related to the mRNA technology used in the COVID-19 vaccines
Moderna, Pfizer and BioNTech were named in lawsuits Tuesday that accuse them of stealing a patented method developed by researchers from The Scripps Research Institute that made the COVID-19 vaccine possible.
The patent at the center of the complaints is a novel method for modifying messenger RNA, or mRNA — which delivers instructions to a cell for protein production. The modification from researchers ultimately made mRNA vaccines safer and significantly more effective by helping the immune system produce sufficient proteins to fight the virus with small doses of mRNA. The technique was developed by Scripps scientists Edelman, Mauro, Stephen Chappell and Wei Zhou in 2009, the lawsuit states.
The lawsuit filed against Pfizer and BioNTech alleges that in 2015, Promosome shared the technology with BioNTech scientist, Dr. Katalin Karikó, but neither company licensed the technology.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Suburban Mosaic: How local spellers fared in the Scripps National Spelling BeeFour young spellers made an impressive stand on the most competitive national linguistic stage last week.
Read more »
Scripps Spelling Bee winner Dev Shah rings NASDAQ closing bellThe 2023 Scripps National Spelling Bee winner joined in a U.S. tradition nearly a century old to help ring the NASDAQ closing bell.
Read more »
Multiple people shot at high school graduation in Richmond, VirginiaBREAKING: Sources say there were at least four victims in the shooting at a high school graduation in Richmond, Virginia.
Read more »
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAdding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.
Read more »
Moderna and Merck Cancer Vaccine Used With Keytruda Reduces Risk of Deadly Skin Cancer SpreadingMelanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.
Read more »
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAn experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy treatment alone, the companies reported on Monday.
Read more »